Table 4.
Quality of life, illness perceptions, and treatment satisfaction.
| Questionnaires | Participating patients (n=57) |
Nonparticipating patients (n=97) |
P value |
| Number of questionnaires returned, n (%) | 45 (79) | 21 (22) |
|
| EQ-5D health state utility score, median (IQRa) | 1.0 (0.16) | 0.89 (0.19) | .20 |
| EQ VASb (range 0-100), mean (SD) | 75.9 (11.5) | 77.2 (13.7) | .68 |
| BIPQc consequences (range 0-10) median (IQRa) | 3.0 (5) | 1.0 (5) | .27 |
| BIPQ timeline (range 0-10), median (IQRa) | 10.0 (2) | 8.0 (4) | .03 |
| BIPQ personal control (range 0-10), median (IQRa) | 8.0 (1) | 6.0 (4) | .21 |
| BIPQ treatment control (range 0-10), median (IQRa) | 8.0 (2) | 8.0 (2) | .06 |
| BIPQ identity(range 0-10), median (IQRa) | 2.0 (3) | 2.0 (4) | .58 |
| BIPQ concern (range 0-10), median (IQRa) | 4.0 (5) | 2.0 (7) | .89 |
| BIPQ understanding (range 0-10), median (IQRa) | 8.0 (2) | 7.0 (3) | .16 |
| BIPQ emotional response (range 0-10), median (IQRa) | 2.0 (4) | 1.0 (3) | .33 |
| DTSQd total score (range 0-48), median (IQRa) | 40.0 (6) | 44.0 (10) | .05 |
aIQR: interquartile range.
bEQ VAS: EQ visual analogue scale.
cBIPQ: Brief Illness Perception Questionnaire.
dDTSQ: Diabetes Treatment Satisfaction Questionnaire.